Copyright Reports & Markets. All rights reserved.

Global FPR1 Inhibitor Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global FPR1 Inhibitor Consumption Value by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Protein Inhibitors
    • 1.3.3 RNA or DNA Inhibitors
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global FPR1 Inhibitor Consumption Value by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Biomedicine
    • 1.4.3 Drug Discovery
    • 1.4.4 Clinical Diagnosis
  • 1.5 Global FPR1 Inhibitor Market Size & Forecast
    • 1.5.1 Global FPR1 Inhibitor Consumption Value (2019 & 2023 & 2030)
    • 1.5.2 Global FPR1 Inhibitor Sales Quantity (2019-2030)
    • 1.5.3 Global FPR1 Inhibitor Average Price (2019-2030)

2 Manufacturers Profiles

  • 2.1 MedChemExpress (MCE)
    • 2.1.1 MedChemExpress (MCE) Details
    • 2.1.2 MedChemExpress (MCE) Major Business
    • 2.1.3 MedChemExpress (MCE) FPR1 Inhibitor Product and Services
    • 2.1.4 MedChemExpress (MCE) FPR1 Inhibitor Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 MedChemExpress (MCE) Recent Developments/Updates
  • 2.2 Merck
    • 2.2.1 Merck Details
    • 2.2.2 Merck Major Business
    • 2.2.3 Merck FPR1 Inhibitor Product and Services
    • 2.2.4 Merck FPR1 Inhibitor Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Merck Recent Developments/Updates
  • 2.3 Cayman Chemical
    • 2.3.1 Cayman Chemical Details
    • 2.3.2 Cayman Chemical Major Business
    • 2.3.3 Cayman Chemical FPR1 Inhibitor Product and Services
    • 2.3.4 Cayman Chemical FPR1 Inhibitor Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Cayman Chemical Recent Developments/Updates
  • 2.4 Santa Cruz Biotechnology
    • 2.4.1 Santa Cruz Biotechnology Details
    • 2.4.2 Santa Cruz Biotechnology Major Business
    • 2.4.3 Santa Cruz Biotechnology FPR1 Inhibitor Product and Services
    • 2.4.4 Santa Cruz Biotechnology FPR1 Inhibitor Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Santa Cruz Biotechnology Recent Developments/Updates
  • 2.5 R&D Systems
    • 2.5.1 R&D Systems Details
    • 2.5.2 R&D Systems Major Business
    • 2.5.3 R&D Systems FPR1 Inhibitor Product and Services
    • 2.5.4 R&D Systems FPR1 Inhibitor Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 R&D Systems Recent Developments/Updates
  • 2.6 Abcam
    • 2.6.1 Abcam Details
    • 2.6.2 Abcam Major Business
    • 2.6.3 Abcam FPR1 Inhibitor Product and Services
    • 2.6.4 Abcam FPR1 Inhibitor Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Abcam Recent Developments/Updates
  • 2.7 Selleck Chemicals
    • 2.7.1 Selleck Chemicals Details
    • 2.7.2 Selleck Chemicals Major Business
    • 2.7.3 Selleck Chemicals FPR1 Inhibitor Product and Services
    • 2.7.4 Selleck Chemicals FPR1 Inhibitor Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Selleck Chemicals Recent Developments/Updates
  • 2.8 Tocris Bioscience
    • 2.8.1 Tocris Bioscience Details
    • 2.8.2 Tocris Bioscience Major Business
    • 2.8.3 Tocris Bioscience FPR1 Inhibitor Product and Services
    • 2.8.4 Tocris Bioscience FPR1 Inhibitor Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 Tocris Bioscience Recent Developments/Updates
  • 2.9 ApexBio Technology
    • 2.9.1 ApexBio Technology Details
    • 2.9.2 ApexBio Technology Major Business
    • 2.9.3 ApexBio Technology FPR1 Inhibitor Product and Services
    • 2.9.4 ApexBio Technology FPR1 Inhibitor Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 ApexBio Technology Recent Developments/Updates
  • 2.10 ChemBridge Corporation
    • 2.10.1 ChemBridge Corporation Details
    • 2.10.2 ChemBridge Corporation Major Business
    • 2.10.3 ChemBridge Corporation FPR1 Inhibitor Product and Services
    • 2.10.4 ChemBridge Corporation FPR1 Inhibitor Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 ChemBridge Corporation Recent Developments/Updates
  • 2.11 APPTEC
    • 2.11.1 APPTEC Details
    • 2.11.2 APPTEC Major Business
    • 2.11.3 APPTEC FPR1 Inhibitor Product and Services
    • 2.11.4 APPTEC FPR1 Inhibitor Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.11.5 APPTEC Recent Developments/Updates
  • 2.12 Liding Biotechnology
    • 2.12.1 Liding Biotechnology Details
    • 2.12.2 Liding Biotechnology Major Business
    • 2.12.3 Liding Biotechnology FPR1 Inhibitor Product and Services
    • 2.12.4 Liding Biotechnology FPR1 Inhibitor Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.12.5 Liding Biotechnology Recent Developments/Updates
  • 2.13 Zhiyuan Biotechnology
    • 2.13.1 Zhiyuan Biotechnology Details
    • 2.13.2 Zhiyuan Biotechnology Major Business
    • 2.13.3 Zhiyuan Biotechnology FPR1 Inhibitor Product and Services
    • 2.13.4 Zhiyuan Biotechnology FPR1 Inhibitor Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.13.5 Zhiyuan Biotechnology Recent Developments/Updates

3 Competitive Environment: FPR1 Inhibitor by Manufacturer

  • 3.1 Global FPR1 Inhibitor Sales Quantity by Manufacturer (2019-2024)
  • 3.2 Global FPR1 Inhibitor Revenue by Manufacturer (2019-2024)
  • 3.3 Global FPR1 Inhibitor Average Price by Manufacturer (2019-2024)
  • 3.4 Market Share Analysis (2023)
    • 3.4.1 Producer Shipments of FPR1 Inhibitor by Manufacturer Revenue ($MM) and Market Share (%): 2023
    • 3.4.2 Top 3 FPR1 Inhibitor Manufacturer Market Share in 2023
    • 3.4.3 Top 6 FPR1 Inhibitor Manufacturer Market Share in 2023
  • 3.5 FPR1 Inhibitor Market: Overall Company Footprint Analysis
    • 3.5.1 FPR1 Inhibitor Market: Region Footprint
    • 3.5.2 FPR1 Inhibitor Market: Company Product Type Footprint
    • 3.5.3 FPR1 Inhibitor Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global FPR1 Inhibitor Market Size by Region
    • 4.1.1 Global FPR1 Inhibitor Sales Quantity by Region (2019-2030)
    • 4.1.2 Global FPR1 Inhibitor Consumption Value by Region (2019-2030)
    • 4.1.3 Global FPR1 Inhibitor Average Price by Region (2019-2030)
  • 4.2 North America FPR1 Inhibitor Consumption Value (2019-2030)
  • 4.3 Europe FPR1 Inhibitor Consumption Value (2019-2030)
  • 4.4 Asia-Pacific FPR1 Inhibitor Consumption Value (2019-2030)
  • 4.5 South America FPR1 Inhibitor Consumption Value (2019-2030)
  • 4.6 Middle East & Africa FPR1 Inhibitor Consumption Value (2019-2030)

5 Market Segment by Type

  • 5.1 Global FPR1 Inhibitor Sales Quantity by Type (2019-2030)
  • 5.2 Global FPR1 Inhibitor Consumption Value by Type (2019-2030)
  • 5.3 Global FPR1 Inhibitor Average Price by Type (2019-2030)

6 Market Segment by Application

  • 6.1 Global FPR1 Inhibitor Sales Quantity by Application (2019-2030)
  • 6.2 Global FPR1 Inhibitor Consumption Value by Application (2019-2030)
  • 6.3 Global FPR1 Inhibitor Average Price by Application (2019-2030)

7 North America

  • 7.1 North America FPR1 Inhibitor Sales Quantity by Type (2019-2030)
  • 7.2 North America FPR1 Inhibitor Sales Quantity by Application (2019-2030)
  • 7.3 North America FPR1 Inhibitor Market Size by Country
    • 7.3.1 North America FPR1 Inhibitor Sales Quantity by Country (2019-2030)
    • 7.3.2 North America FPR1 Inhibitor Consumption Value by Country (2019-2030)
    • 7.3.3 United States Market Size and Forecast (2019-2030)
    • 7.3.4 Canada Market Size and Forecast (2019-2030)
    • 7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe

  • 8.1 Europe FPR1 Inhibitor Sales Quantity by Type (2019-2030)
  • 8.2 Europe FPR1 Inhibitor Sales Quantity by Application (2019-2030)
  • 8.3 Europe FPR1 Inhibitor Market Size by Country
    • 8.3.1 Europe FPR1 Inhibitor Sales Quantity by Country (2019-2030)
    • 8.3.2 Europe FPR1 Inhibitor Consumption Value by Country (2019-2030)
    • 8.3.3 Germany Market Size and Forecast (2019-2030)
    • 8.3.4 France Market Size and Forecast (2019-2030)
    • 8.3.5 United Kingdom Market Size and Forecast (2019-2030)
    • 8.3.6 Russia Market Size and Forecast (2019-2030)
    • 8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific

  • 9.1 Asia-Pacific FPR1 Inhibitor Sales Quantity by Type (2019-2030)
  • 9.2 Asia-Pacific FPR1 Inhibitor Sales Quantity by Application (2019-2030)
  • 9.3 Asia-Pacific FPR1 Inhibitor Market Size by Region
    • 9.3.1 Asia-Pacific FPR1 Inhibitor Sales Quantity by Region (2019-2030)
    • 9.3.2 Asia-Pacific FPR1 Inhibitor Consumption Value by Region (2019-2030)
    • 9.3.3 China Market Size and Forecast (2019-2030)
    • 9.3.4 Japan Market Size and Forecast (2019-2030)
    • 9.3.5 South Korea Market Size and Forecast (2019-2030)
    • 9.3.6 India Market Size and Forecast (2019-2030)
    • 9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
    • 9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America

  • 10.1 South America FPR1 Inhibitor Sales Quantity by Type (2019-2030)
  • 10.2 South America FPR1 Inhibitor Sales Quantity by Application (2019-2030)
  • 10.3 South America FPR1 Inhibitor Market Size by Country
    • 10.3.1 South America FPR1 Inhibitor Sales Quantity by Country (2019-2030)
    • 10.3.2 South America FPR1 Inhibitor Consumption Value by Country (2019-2030)
    • 10.3.3 Brazil Market Size and Forecast (2019-2030)
    • 10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa

  • 11.1 Middle East & Africa FPR1 Inhibitor Sales Quantity by Type (2019-2030)
  • 11.2 Middle East & Africa FPR1 Inhibitor Sales Quantity by Application (2019-2030)
  • 11.3 Middle East & Africa FPR1 Inhibitor Market Size by Country
    • 11.3.1 Middle East & Africa FPR1 Inhibitor Sales Quantity by Country (2019-2030)
    • 11.3.2 Middle East & Africa FPR1 Inhibitor Consumption Value by Country (2019-2030)
    • 11.3.3 Turkey Market Size and Forecast (2019-2030)
    • 11.3.4 Egypt Market Size and Forecast (2019-2030)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
    • 11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics

  • 12.1 FPR1 Inhibitor Market Drivers
  • 12.2 FPR1 Inhibitor Market Restraints
  • 12.3 FPR1 Inhibitor Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of FPR1 Inhibitor and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of FPR1 Inhibitor
  • 13.3 FPR1 Inhibitor Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 FPR1 Inhibitor Typical Distributors
  • 14.3 FPR1 Inhibitor Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    FPR1 inhibitor is a compound or substance used to inhibit the activity of FPR1 (Formyl Peptide Receptor 1, N-formyl peptide receptor 1). FPR1 is a G protein-coupled receptor that is involved in regulating biological processes such as inflammation, immunity, and cell migration. FPR1 inhibitors bind to FPR1 and block its signaling pathway, thereby inhibiting its related biological responses. These inhibitors are often used in scientific research to explore the role of FPR1 in physiological and pathological processes and may serve as potential drug targets for the development of disease treatments.
    According to our (Global Info Research) latest study, the global FPR1 Inhibitor market size was valued at US$ 88.8 million in 2023 and is forecast to a readjusted size of USD 124 million by 2030 with a CAGR of 4.9% during review period.
    The FPR1 inhibitor market has shown a steady development trend in recent years. With in-depth research on the biological functions of FPR1 (Formyl Peptide Receptor 1), its key role in inflammatory response, cell migration, cancer development and other processes has been gradually revealed, which has promoted the development and application of FPR1 inhibitors. FPR1 inhibitors are mainly used in scientific research experiments, especially in drug discovery and mechanism research, playing an important role. They provide researchers with tools to regulate FPR1 function to gain insights into related physiological processes and develop novel treatments. In summary, the FPR1 inhibitor market has broad development prospects and huge market potential.
    This report is a detailed and comprehensive analysis for global FPR1 Inhibitor market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
    Key Features:
    Global FPR1 Inhibitor market size and forecasts, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2019-2030
    Global FPR1 Inhibitor market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2019-2030
    Global FPR1 Inhibitor market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2019-2030
    Global FPR1 Inhibitor market shares of main players, shipments in revenue ($ Million), sales quantity (K Dose), and ASP (US$/Dose), 2019-2024
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for FPR1 Inhibitor
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global FPR1 Inhibitor market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include MedChemExpress (MCE), Merck, Cayman Chemical, Santa Cruz Biotechnology, R&D Systems, Abcam, Selleck Chemicals, Tocris Bioscience, ApexBio Technology, ChemBridge Corporation, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    FPR1 Inhibitor market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Protein Inhibitors
    RNA or DNA Inhibitors
    Market segment by Application
    Biomedicine
    Drug Discovery
    Clinical Diagnosis
    Major players covered
    MedChemExpress (MCE)
    Merck
    Cayman Chemical
    Santa Cruz Biotechnology
    R&D Systems
    Abcam
    Selleck Chemicals
    Tocris Bioscience
    ApexBio Technology
    ChemBridge Corporation
    APPTEC
    Liding Biotechnology
    Zhiyuan Biotechnology
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe FPR1 Inhibitor product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of FPR1 Inhibitor, with price, sales quantity, revenue, and global market share of FPR1 Inhibitor from 2019 to 2024.
    Chapter 3, the FPR1 Inhibitor competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the FPR1 Inhibitor breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and FPR1 Inhibitor market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of FPR1 Inhibitor.
    Chapter 14 and 15, to describe FPR1 Inhibitor sales channel, distributors, customers, research findings and conclusion.

    Buy now